Literature DB >> 28980330

The fentanyl family: A distinguished medical history tainted by abuse.

R B Raffa1,2, J V Pergolizzi3, J A LeQuang3, R Taylor3, S Colucci4, M H Annabi5.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Beginning in the 1950s, a family of potent opioids was synthesized and developed (fentanyl and analogues). They continue to serve as valuable analgesic agents. But the recent spike and notoriety of their abuse has raised alarm, even calls for tighter control. We review the trajectory of these compounds. COMMENT: To rectify shortcomings of the then available opioid analgesics, an analogue family of compounds was synthesized having a piperidine ring (presumptive principal active moiety in morphine and meperidine). The result was more potent and rapid-acting compounds, including alfentanil, carfentanil, fentanyl, sufentanil and others. These properties, plus availability in formulations for multiple routes of administration, impart broad therapeutic utility. They also unfortunately favour abuse. WHAT IS NEW AND
CONCLUSION: The abuse of fentanyl and its analogues (legal and illicit) serves as a case study for the dilemma and difficulties balancing a medical need against psychosocial realities. The fentanyl family provides relief for severe pain, but their very properties also engender abuse.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  analgesia; drug abuse; fentanyl; opioid; pharmacologic family

Mesh:

Substances:

Year:  2017        PMID: 28980330     DOI: 10.1111/jcpt.12640

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  8 in total

1.  At-a-glance - Lessons learned from launching the Manitoba Take-Home Naloxone Program.

Authors:  Songul Bozat-Emre; Shelley G Marshall; Colin Zhong; Joss Reimer
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-06       Impact factor: 3.240

2.  P2RX7 Gene rs1718125 Polymorphism is Related with Postoperative Pain and Fentanyl Intake in Esophageal Cancer Patients.

Authors:  Cuijuan Zheng; Jiayu Wang; Shouxiang Xie
Journal:  Pharmgenomics Pers Med       Date:  2020-11-12

3.  A deadly trend in fentanyl fatalities (England, 1998-2017).

Authors:  Hugh Claridge; Bryn D Williams; Caroline S Copeland
Journal:  Br J Clin Pharmacol       Date:  2020-01-23       Impact factor: 4.335

4.  Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids.

Authors:  Renata Solimini; Simona Pichini; Roberta Pacifici; Francesco P Busardò; Raffaele Giorgetti
Journal:  Front Pharmacol       Date:  2018-06-20       Impact factor: 5.810

5.  Correlation of P2RX7 gene rs1718125 polymorphism with postoperative fentanyl analgesia in patients with lung cancer.

Authors:  Jin Ma; Wenyao Li; Qing Chai; Xiaohong Tan; Kexian Zhang
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

6.  The analgesic effects of β-elemene in rats with neuropathic pain by inhibition of spinal astrocytic ERK activation.

Authors:  Li-Tian Ma; Yang Bai; Peng Cao; Kai-Xi Ren; Jing Chen; Ting Zhang; Bo-Yuan Fan; Yu Qiao; Hong-Yu Yan; Jing-Jie Wang; Yun-Qing Li; Jin Zheng
Journal:  Mol Pain       Date:  2022-04       Impact factor: 3.370

7.  Cold Denaturation of Proteins in the Absence of Solvent: Implications for Protein Storage.

Authors:  Emma L Norgate; Rosie Upton; Kjetil Hansen; Bruno Bellina; C Brookes; Argyris Politis; Perdita E Barran
Journal:  Angew Chem Int Ed Engl       Date:  2022-04-21       Impact factor: 16.823

8.  Safety, Tolerability, and Dose Proportionality of a Novel Transdermal Fentanyl Matrix Patch and Bioequivalence With a Matrix Fentanyl Patch: Two Phase 1 Single-Center Open-Label, Randomized Crossover Studies in Healthy Japanese Volunteers.

Authors:  Ulrike Lorch; Tomasz Pierscionek; Anne Freier; Christopher S Spencer; Jörg Täubel
Journal:  Clin Pharmacol Drug Dev       Date:  2020-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.